Mirantus Health

Mirantus Health GmbH is a Berlin-based health technology company that provides non-medical eye examinations aimed at early detection of eye conditions, without issuing diagnoses. Its software platform, called mira, guides trained opticians and optometrists through a roughly 15-minute examination comprising visual acuity testing, refraction/spectacle lens determination, retinal imaging, intraocular pressure measurement and slit-lamp photography. The captured data is transmitted digitally to a Germany-wide network of ophthalmologists, who return a written result report within 24 to 48 hours indicating whether abnormalities warrant follow-up with a physician. Where abnormalities are found, patients can request appointments with partner practices. The company states explicitly that it is not a medical service provider, does not make diagnoses, and that the report does not replace examination or treatment by an ophthalmologist; the service is not intended for people with acute eye problems.

Delivery combines fixed screening points at partner opticians with mobile units branded "Augenmobil" that bring screening to rural communities and nursing homes using the same digital workflow. Earlier company descriptions positioned Mirantus more broadly as bringing specialist care to European long-term care recipients and rural residents via telemedicine and point-of-care diagnostics, starting with nursing homes. Sources published in late 2025 describe the company as operating at over 200 locations, primarily in northern and eastern Germany, with plans to expand nationwide and into Austria and Switzerland.

The website cites 250+ locations, 25,000+ satisfied customers and 400+ physician partners in some places and 20,000+ customers, 250+ examination sites and 350+ partner ophthalmologists in others, so the self-reported figures are internally inconsistent.

Founding story

The company emerged from a research project; the mira platform was initially developed and scientifically validated for the founders' own use, then broadened to reach more people. Coverage names Dominik Pederzani as founder and CEO, with Claus Gruber as co-founder; a Handelsblatt photo caption identifies Philipp Deutschen, Claus Gruber and Dominik Pederzani as the founders.

Business model

Mirantus supplies the mira software platform and screening workflow to opticians, who perform the examination on site, while Mirantus organises remote evaluation by contracted ophthalmologists and onward referral to partner practices. The offering is positioned as complementary to the statutory panel-physician (Kassenärztliche Vereinigung) channel rather than a replacement for it, and is intended to reduce load on existing ophthalmology practices.

The company's own site lists a price of EUR 69 for the comprehensive eye examination, including all measurements and the written result report from an ophthalmologist, with the price potentially varying when the check takes place on a partner optician's premises. Press coverage of the wider category notes consumers paying around EUR 50 for such a test.

Traction

As of late 2025 the company reported roughly 20 employees, activity at more than 200 locations and tens of thousands of people supported per year; the website cites 250+ locations, 20,000-25,000+ customers and 350-400+ partner ophthalmologists. More than 400 partner ophthalmologists are cited in press coverage. The stated goal is more than 1,000 locations across the DACH region by 2027.

Latest developments

In November 2025 Mirantus Health announced a EUR 5.5 million seed financing round backed by Revent, Redstone, Entrepreneur First, Noaber, Arve Capital and angel investors including Kai Eberhardt (Oviva) and Katharina Jünger (TeleClinic). Proceeds are earmarked for the DACH-wide rollout and further development of the mira software and expansion from around 200 to more than 1,000 locations by 2027. A founder interview published in December 2025 put headcount at about 20.